The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer

Official record

Identifier

NCT04065009

Recruiting locations

country

Sweden

Interventions studied

RopivacaineSaline Solution

Lead sponsor

Karolinska Institutet

Target enrolment

220 participants

Study type

INTERVENTIONAL

Phase

Phase 3

Status

Active, not recruiting

First posted

Aug 22, 2019

Last updated on the registry

Sep 28, 2026

Age

18 Years – 80 Years

Sex

FEMALE

Study contact

No public contact is listed on the official record.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* ASA I-III
* Scheduled for upfront cytoreductive surgery for presumed stage III or IV epithelial ovarian cancer
* Signed written informed consent

Exclusion Criteria:

* Contraindication to epidural anesthesia
* Allergy to any component drugs used during epidural or intraperitoneal anesthesia (Ropivacaine, Sufentanil)
* Uncontrolled renal, liver, heart failure or ischemic heart disease
* Speech, language or cognitive difficulties
* Women in whom cytoreductive surgery is not attempted at time of upfront laparotomy due to extent of disease

Indexed under

Ovarian Cancer